TGA investigates duloxetine contamination

medicine capsules
Sponsors report N-nitroso-duloxetine levels in some duloxetine medications are currently above “acceptable intake” limits  Patients are being urged not to stop taking duloxetine medications while the Therapeutic Goods Administration (TGA) investigates reports of contamination.   In a safety advisory issued by the TGA on Monday (27 November), the regulator noted that a number of sponsors

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Former nurse lied to get opioids, court told
Next TGA quarantines Interpharma saline products